Concepedia

Akiko Todaka

AT

Statistics

Publications

1

Citations

22

H-Index

1

Active since

2023

Affiliations

Tokyo National Hospital(Current)

Akiko Todaka is an author at Tokyo National Hospital specializing in cancer therapeutics, oncology, and tumor biology.

Top concepts

MedicineOncologyPathologyPharmacologyTumor BiologyCancer TherapyCancer ResearchPharmacotherapyMolecular OncologyRadiation Oncology

Publications per year

2023–2023

1

Publications

1

Nanvuranlat, an L-type amino acid transporter (LAT1) inhibitor for patients with pretreated advanced refractory biliary tract cancer (BTC): Primary endpoint results of a randomized, double-blind, placebo-controlled phase 2 study.

Junji Furuse, Masafumi Ikeda, Makoto Ueno et al. · Journal of Clinical Oncology · 2023 · 22 citations

Placebo-controlled Phase 2, Pathology, Pharmacotherapy +16

1–1 of 1